Medtronic Broadens Drug Delivery Options With EndoBionics Purchase
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's equity investment in privately held EndoBionics for injectable drug delivery technology complements Medtronic's existing drug-eluting stent platform